|
Volumn 355, Issue 6330, 2017, Pages 1129-1130
|
Developing an HIV vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B LYMPHOCYTE RECEPTOR;
EPITOPE;
FC RECEPTOR;
GLYCOPROTEIN GP 120;
GLYCOSYLATED PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN HEAVY CHAIN;
NEUTRALIZING ANTIBODY;
VIRUS ENVELOPE PROTEIN;
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE;
RECOMBINANT VACCINE;
ANTIBODY;
DISEASE TRANSMISSION;
DISEASE VECTOR;
GENETIC ENGINEERING;
GENOME;
HUMAN IMMUNODEFICIENCY VIRUS;
PROTEIN;
RODENT;
VACCINE;
VIRUS;
ANTIBODY RESPONSE;
CD8+ T LYMPHOCYTE;
CELL KILLING;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNIZATION;
IMMUNOLOGICAL TOLERANCE;
NONHUMAN;
PRE B LYMPHOCYTE;
PRIORITY JOURNAL;
SHORT SURVEY;
SIMIAN IMMUNODEFICIENCY VIRUS;
SOMATIC HYPERMUTATION;
VACCINATION;
VIRUS DNA CELL DNA INTERACTION;
ANIMAL;
CLINICAL TRIAL (TOPIC);
CYTOTOXIC T LYMPHOCYTE;
GENETICS;
HIV INFECTIONS;
IMMUNOLOGY;
MOUSE;
PROTEIN MULTIMERIZATION;
VACCINE IMMUNOGENICITY;
THAILAND;
AIDS VACCINES;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HIV PROTEASE;
HUMANS;
IMMUNOGENICITY, VACCINE;
MICE;
PROTEIN MULTIMERIZATION;
T-LYMPHOCYTES, CYTOTOXIC;
VACCINES, SYNTHETIC;
|
EID: 85015254062
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aan0662 Document Type: Short Survey |
Times cited : (75)
|
References (15)
|